Nine years survival with non-small cell lung cancer. Case report

Abstract

Lung cancer is the most frequent tumour worldwide. In Poland lung cancer has the highest incidence of any cancerin the male population. It has a poor survival prognosis and is the most frequent cause of death in the general population. The Polish forecast for year 2025 shows that the mortality rate will increase, especially in the group over 70 years old. Generally modality treatment depends on staging system. The first management step for non-small cell lung cancer is to decide whether the treatment aim is definitive or palliative and whether the tumour is resectable or unresectable. Survival rate in stage III according to many authors is some 17 months, but in the case of generalised disease is only about 9 months. The authors present a case report of 9 years survival with initial clinical stage IIIA, thereafter with disease stage IV.